Development and Validation of a Short Tool to Assess the Awareness of Pregnancy-induced Hypertension

Background: Pregnancy-induced hypertension (PIH) is responsible for most perinatal and fetal mortality. Few programs are patient-centered during pregnancy, increasing the risks of misinformation and misconceptions among pregnant women and, as a result, malpractices. Objective: This study aims to develop and validate a form to assess the knowledge and attitudes of pregnant women about PIH.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy Related Cardiovascular Diseases Female Urogenital Diseases and Pregnancy Complications Hypertension Hypertension in Pregnancy Hypertension, Pregnancy-Induced Pregnancy Complications Urogenital Diseases Vascular Diseases

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Lebanese University Faculty of pharmacy

Beirut, 0000, Lebanon

About this study

Many observational studies explored the awareness of pregnant women of PIH, but no structured tool is available to assess such awareness. During the past two years, education campaigns were postponed and primary care was prioritized. To allow better-informed decisions and targeted actions, this pilot study aims to develop and validate a short form to assess the knowledge and attitudes of pregnant women about pregnancy-induced hypertension. The long-term objective of this study is to provide a practical tool for pregnant women.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants were asked to participate in the study with no criteria based on race, ethnicity, or gestational age.

Exclusion criteria

Those with a history of hypertension or pre-eclampsia were excluded.

Treatment and study plan

survey

Behavioral

A short 25-item tool was developed and can be applied in clinics to assess the awareness of pregnancy hypertension.

Primary outcomes

Awareness of hypertensive disorders of pregnancy by developing a 25-item questionnaire

Time frame: 6 months

Thirty-six statements were initially provided to which women had to answer either ''yes'', ''No'' or ''I don't Know''. Out of these statements, 25 were retained due to positive inter-item correlation (15 knowledge statements and 10 behavior statements), and the other statements were eliminated one by one after testing for reliability and computing the effect of each statement on the internal consistency.

Sponsors and collaborators

Lead sponsor

Georges Hatem

Other

Registry information

Official study title

Development and Validation of a Short Tool to Assess the Awareness of Pregnancy-induced Hypertension: A Cross-sectional Study Among Pregnant Women in Lebanon

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: May 15, 2023
Registry last updated: May 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed